Junbin Wang
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 6
- Viral Infections and Vectors 2
-
- interferon and immune responses 2
- Co-authors
- G. Scott Worthen (1 shared paper)Kai Feng (1 shared paper)Xiang Wang (1 shared paper)Jie Song (1 shared paper)Lei Guo (1 shared paper)Huiwen Zheng (1 shared paper)Cong Tang (11 shared papers)Fengmei Yang (3 shared papers)
- Journals
- Gut Microbes (1 paper)Microbiome (1 paper)npj Vaccines (1 paper)Journal of Medical Virology (1 paper)Emerging Microbes & Infections (1 paper)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Junbin Wang
14 papers receiving 169 citations
Peers
Comparison fields: 5 of 63
- Infectious Diseases 41
- Internal Medicine 7
- Immunology 42
- Biological Psychiatry 4
- Hematology 18
Countries citing papers authored by Junbin Wang
This map shows the geographic impact of Junbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbin Wang more than expected).
Fields of papers citing papers by Junbin Wang
This network shows the impact of papers produced by Junbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbin Wang. The network helps show where Junbin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Junbin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 53 | |
| 2 | 2023 | 32 | |
| 3 | 2019 | 23 | |
| 4 | 2020 | 13 | |
| 5 | 2020 | 11 | |
| 6 | 2023 | 11 | |
| 7 | 2022 | 10 | |
| 8 | 2023 | 4 | |
| 9 | 2025 | 3 | |
| 10 | 2023 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2024 | 2 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Junbin Wang
Junbin Wang is a scholar working on Infectious Diseases, Immunology, Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 16 papers that have together received 171 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers), Mosquito-borne diseases and control (2 papers), interferon and immune responses (2 papers), Gut microbiota and health (2 papers), Viral Infections and Immunology Research (2 papers), Viral Infections and Vectors (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (1 paper). The work is most often cited by research in Infectious Diseases (41 citations), Internal Medicine (7 citations), Immunology (42 citations), Biological Psychiatry (4 citations) and Hematology (18 citations). Junbin Wang has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include G. Scott Worthen, Kai Feng, Xiang Wang, Jie Song, Lei Guo, Huiwen Zheng, Cong Tang, Fengmei Yang, Wenhai Yu and Xiaozhong Peng. Their work appears in journals such as Gut Microbes, Microbiome, npj Vaccines, Journal of Medical Virology and Emerging Microbes & Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.